IceCure Medical (ICCM) Research & Development (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Research & Development data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Research & Development rose 32.87% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $8.0 million, a 17.2% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 4.75% from the prior year.
• Research & Development for Q1 2026 stood at $2.2 million, down from $2.3 million in the prior quarter.
• Over the last five years, Research & Development for ICCM reached as high as $2.4 million in Q1 2022 and fell as low as -$3.7 million in Q4 2022.
• Historically, Research & Development has averaged $1.7 million across 5 years, with a median of $2.0 million in 2024.
• Across the five-year window, Research & Development soared 151.14% in 2023 and retreated 23.76% in 2024, its largest moves.
• Year by year, Research & Development stood at -$3.7 million in 2022, then surged by 151.14% to $1.9 million in 2023, then decreased by 9.98% to $1.7 million in 2024, then surged by 35.46% to $2.3 million in 2025, then slipped by 3.7% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.2 million in Q1 2026, $2.3 million in Q4 2025, and $1.8 million in Q3 2025.